Login / Signup

Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects.

Allison GaudyChristian AtsrikuYing YeKimberly MacGormanLiangang LiuYongjun XueSekhar SurapaneniMaria Palmisano
Published in: European journal of clinical pharmacology (2020)
Clinical trial identification number is NCT02820935 and was registered in July 2016.
Keyphrases
  • clinical trial
  • open label
  • double blind
  • adverse drug
  • phase ii
  • drug induced
  • emergency department
  • randomized controlled trial
  • climate change
  • bioinformatics analysis